Timber Hill’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-22,400
Closed -$2.59M 1100
2017
Q1
$2.59M Sell
22,400
-13,200
-37% -$1.53M 0.02% 594
2016
Q4
$4.27M Buy
35,600
+13,000
+58% +$1.44M 0.02% 586
2016
Q3
$2.54M Sell
22,600
-15,700
-41% -$1.81M 0.01% 710
2016
Q2
$4.75M Buy
38,300
+8,600
+29% +$1.04M 0.02% 547
2016
Q1
$3.34M Sell
29,700
-800
-3% -$83.1K 0.02% 680
2015
Q4
$3.32M Buy
30,500
+15,900
+109% +$1.82M 0.02% 726
2015
Q3
$1.46M Buy
14,600
+1,700
+13% +$185K 0.01% 1194
2015
Q2
$1.47M Buy
12,900
+1,600
+14% +$194K 0.01% 1282
2015
Q1
$1.18M Buy
+11,300
New +$1.2M 0.01% 1324
2013
Q4
Sell
-5,500
Closed -$931K 2988
2013
Q3
$931K Sell
5,500
-18,600
-77% -$2.89M ﹤0.01% 1998
2013
Q2
$3.65M Buy
+24,100
New +$3.41M 0.01% 1009

Other funds holding CLB

Timber Hill's CLB Position: Q2 2017 in Review

Timber Hill sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 6,655 shares — an estimated $769K sold.

Timber Hill first reported a position in CLB in Q2 2015 and held it in 5 quarters. The position peaked at $1.15M in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Timber Hill reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 6,655 Core Laboratories shares in Q2 2017, an estimated $769K.
  • Timber Hill first reported a position in Core Laboratories in Q2 2015 and held it in 5 quarters.
  • Timber Hill's Core Laboratories position peaked at $1.15M in Q2 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.